학술논문
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer
Document Type
Article
Author
Source
In European Urology November 2022 82(5):518-526
Subject
Language
ISSN
0302-2838